For many patients, a diagnosis of advanced lung cancer can feel like the end of the road. However, advances in systemic therapy, complex thoracic surgery and multidisciplinary cancer care are creating new possibilities for carefully selected patients.
A patient treated at Southern Medical University Shenzhen Hospital provides a remarkable example. Eight years after being diagnosed with locally advanced lung cancer, he returned to the hospital in good condition, with follow-up imaging showing no definite signs of recurrence or metastasis.
A Diagnosis That Changed Everything
In May 2018, a 52-year-old patient, referred to here as Mr. Wang, underwent a routine medical examination during a visit to his hometown. A chest CT scan revealed advanced lung cancer.
Further imaging and pathological examinations confirmed squamous cell carcinoma in the upper lobe of his left lung. The tumor had already invaded several critical structures, including the left main pulmonary artery, left main bronchus and left pulmonary vein.
Because the tumor was closely connected to the major blood vessels and airways at the pulmonary hilum, conventional surgical removal carried extremely high risks. Radiotherapy and chemotherapy alone were also unlikely to provide sufficient local control.
Multidisciplinary Treatment Created a Surgical Opportunity
The hospital organized a multidisciplinary team consultation involving specialists from cardiothoracic surgery, oncology, medical imaging, anesthesiology, respiratory and critical care medicine, pathology and nuclear medicine.
Although the cancer was locally advanced, the team believed that treatment might still be possible if systemic therapy could first reduce the size of the tumor.
Mr. Wang therefore received two cycles of neoadjuvant chemotherapy. After treatment, the tumor became smaller and the disease was partially controlled, creating a potential opportunity for surgery.
However, the tumor remained closely attached to the major pulmonary vessels and bronchi. A conventional operation could not completely remove the cancer while preserving enough functioning lung tissue.
The medical team needed a different approach.
What Is Autologous Lung Transplantation?
After extensive evaluation, the cardiothoracic surgery team decided to perform an autologous lung transplantation.
Unlike conventional lung transplantation, this procedure does not involve receiving a lung from a donor. Instead, the patient’s own lung is temporarily removed from the body.
The surgical team then:
- Removes the tumor-bearing portion of the lung outside the body.
- Resects the affected bronchi and blood vessels.
- Reconstructs the remaining healthy lung tissue.
- Reconnects the bronchial and vascular structures.
- Reimplants the reconstructed lung into the patient.
This approach can make it possible to remove tumors involving complex structures while preserving more healthy lung tissue than a complete pneumonectomy.
However, autologous lung transplantation is an exceptionally demanding procedure. It requires advanced surgical expertise, precise reconstruction of pulmonary vessels and bronchi, experienced anesthesia management and close cooperation between multiple medical departments.
Surgery Was Only One Part of the Treatment
The operation was successfully completed following detailed preoperative planning and close multidisciplinary cooperation.
After surgery, Mr. Wang continued to receive chemotherapy and immunotherapy as part of a comprehensive treatment plan. He remained in stable condition for approximately three years.
In 2021, the cancer recurred. Fortunately, further chemotherapy brought the disease under control again. The hospital later lost contact with him, and the medical team did not know how his condition had developed.
An Unexpected Return Eight Years Later
Recently, Mr. Wang returned to the Department of Cardiothoracic Surgery for a follow-up examination.
Eight years after the original diagnosis and major operation, he appeared in good health. Whole-body imaging showed no definite hypermetabolic lesions and no clear evidence of recurrent or metastatic disease. The imaging findings were considered consistent with complete remission.
His experience demonstrates that even some patients with extremely advanced disease may achieve long-term survival when appropriate systemic treatment, complex surgery and long-term follow-up are successfully combined.
What This Case Means for International Patients
This case does not mean that autologous lung transplantation is suitable for every patient with advanced lung cancer. Treatment decisions depend on many factors, including:
- Tumor location and pathological type
- Involvement of major blood vessels and bronchi
- Response to chemotherapy or immunotherapy
- Remaining lung function
- General physical condition
- Presence of distant metastases
- Surgical experience of the medical team
For international patients considering advanced lung cancer treatment in China, obtaining a multidisciplinary medical review is an important first step. Specialists can assess whether conventional surgery, systemic therapy, radiotherapy, immunotherapy or a more complex surgical strategy may be appropriate.
Hope Through Individualized Cancer Treatment
Advanced lung cancer remains a serious and challenging disease. Nevertheless, this eight-year survival story shows that an initially inoperable or extremely difficult tumor does not always mean that all treatment possibilities have been exhausted.
Through neoadjuvant chemotherapy, autologous lung transplantation, postoperative systemic treatment and continued disease management, Mr. Wang achieved an outcome that once seemed impossible.
Every patient’s condition is different, but careful evaluation and individualized treatment may reveal possibilities that are not apparent at the time of diagnosis.
CTA
Seeking advanced lung cancer treatment in China?
Our international patient coordination team can assist with medical record preparation, specialist consultations, hospital communication, translation and treatment arrangements in China.
Contact us to request an initial medical case review.